Recombinant Ostreid herpesvirus 1 Putative transmembrane protein ORF57 (ORF57)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is requested in advance. Additional fees apply for dry ice shipping.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a reference.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The specific tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its development.
Synonyms
ORF57; Putative transmembrane protein ORF57
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-316
Protein Length
full length protein
Species
Ostreid herpesvirus 1 (isolate France) (OsHV-1) (Pacific oyster herpesvirus)
Target Names
ORF57
Target Protein Sequence
MTDAVKKIAKLVVDLHGEKNTQNIIEVAKAGGKESAEAVLFKKLTDAIIKDMTAMINHGD SKEKMQFTSTEQDLPMAEDTTLTNNKLFWFSVVVGIVLFVTAINYLLDKVCWIKAARKIA ITCFLISVCWNYINIYEKTMAKRYMVIRQGIPGGCMERGADWSTVLRTMFKTLMITHSDS NDECLQYAKSIIVEPLFEVTPTTALATTISDLILVPINLAAKSCNNVFRTVFEGVPVFMI PILVFLLVYISTLCIISTKRYTISVPFLLELKPCLVEPPPMVPISVRNETCNVVHKKPVA LRRGLCYNKLFRNKKY
Uniprot No.

Target Background

Database Links

KEGG: vg:2948171

Subcellular Location
Host membrane; Multi-pass membrane protein.

Q&A

What is Ostreid herpesvirus 1 ORF57 and what is its basic structure?

Ostreid herpesvirus 1 (OsHV-1) ORF57 is a putative transmembrane protein consisting of 316 amino acids. The full amino acid sequence is: MTDAVKKIAKLVVDLHGEKNTQNIIEVAKAGGKESAEAVLFKKLTDAIIKDMTAMINHGDSKEKMQFTSTEQDLPMAEDTTLTNNKLFWFSVVVGIVLFVTAINYLLDKVCWIKAARKIAITCFLISVCWNYINIYEKTMAKRYMVIRQGIPGGCMERGADWSTVLRTMFKTLMITHSDSNDECLQYAKSIIVEPLFEVTPTTALATTISDLILVPINLAAKSCNNVFRTVFEGVPVFMIPI . The protein contains hydrophobic regions consistent with its proposed transmembrane function. Preliminary analysis suggests that OsHV-1 ORF57 may share functional similarities with homologous proteins found in other herpesviruses, though considerable sequence divergence exists between herpesvirus families.

How does ORF57 in Ostreid herpesvirus 1 compare to homologous proteins in other herpesviruses?

While Ostreid herpesvirus 1 ORF57 is not as extensively characterized as its homologs in human herpesviruses, comparative analysis reveals important insights. In Kaposi's Sarcoma-Associated Herpesvirus (KSHV), ORF57 functions as a multifunctional regulatory protein essential for viral replication . The ORF57 protein family is highly conserved across mammalian herpesviruses, including human herpesvirus variants, varicella-zoster virus (ORF4), herpes simplex virus (ICP27), and Epstein-Barr virus (SM) . Despite conservation, these proteins demonstrate significant functional and sequence divergence, suggesting virus-specific adaptations . The OsHV-1 ORF57 likely has evolved functions specific to its replication in invertebrate hosts, which distinguishes it from mammalian herpesvirus counterparts.

What expression systems are optimal for producing recombinant OsHV-1 ORF57?

For laboratory-scale production, recombinant OsHV-1 ORF57 has been successfully expressed in E. coli with an N-terminal His-tag . The full-length protein (amino acids 1-316) can be expressed as a soluble fraction when optimal conditions are employed. When working with ORF57, consider the following expression optimization parameters:

ParameterRecommended ConditionsNotes
Expression SystemE. coli BL21(DE3)Good for initial characterization
Induction0.5mM IPTG, 18°C, 16hLower temperature improves solubility
Lysis BufferPBS + 1% Triton X-100Helps solubilize membrane proteins
PurificationNi-NTA chromatographyUtilizing the His-tag
Secondary PurificationSize exclusion chromatographyImproves purity

For functional studies, mammalian expression systems may better preserve native conformation, particularly for studying interactions with host factors. Based on successful expression strategies for KSHV ORF57, mammalian systems could provide properly folded protein with post-translational modifications .

What techniques can be used to assess ORF57 RNA binding capabilities?

Based on knowledge from KSHV ORF57 studies, several techniques can be employed to characterize the RNA binding properties of OsHV-1 ORF57:

  • Electrophoretic mobility shift assays (EMSAs) can determine direct RNA-protein interactions and binding affinities. These have been successfully used with KSHV ORF57 to identify specific RNA binding elements .

  • RNA immunoprecipitation (RIP) followed by sequencing (RIP-seq) can identify RNA targets bound by ORF57 in a cellular context. KSHV ORF57 has been shown to bind specific viral RNAs, particularly PAN RNA, through certain sequence elements .

  • UV cross-linking followed by immunoprecipitation can map the specific nucleotides contacted by the protein. In KSHV, an ORF57-responsive element (ORE) has been identified that confers ORF57 responsiveness to transcripts .

When designing these experiments for OsHV-1 ORF57, researchers should consider potential differences in RNA binding specificity compared to mammalian herpesvirus homologs. The methodologies should include:

TechniquePrimary ReadoutControls Needed
EMSAShifted RNA bandsUnlabeled competitor RNA, mutant ORF57
RIP-seqEnriched RNA sequencesInput RNA, IgG control IP
Cross-linking studiesNucleotide resolution contactsNo-crosslink controls, deletion mutants

What is the role of ORF57 in viral gene expression and replication?

Based on studies of KSHV ORF57, this protein family plays critical roles in viral gene expression through multiple mechanisms. KSHV ORF57 has been demonstrated to be essential for productive lytic viral replication . An ORF57-null KSHV recombinant was unable to produce virion progeny or fully express several lytic viral genes, indicating its essential role in the viral life cycle .

For OsHV-1 ORF57, we would expect similar functional importance, potentially including:

  • Post-transcriptional enhancement of viral gene expression: KSHV ORF57 enhances expression of intronless viral genes posttranscriptionally, which is particularly relevant as the majority of herpesvirus genes lack introns .

  • RNA stabilization: ORF57 is likely to protect viral transcripts from nuclear decay mechanisms. KSHV ORF57 has been shown to bind specific elements in viral RNAs and protect them from degradation .

  • Export of viral mRNAs: The protein may facilitate nuclear export of viral transcripts, though its functions extend beyond serving as a simple adaptor protein for export factors .

Experimental approaches to study these functions in OsHV-1 should include:

  • Generation of ORF57-null mutants to assess replication defects

  • Transcriptome analysis to identify regulated viral and host genes

  • Nuclear/cytoplasmic fractionation to assess effects on RNA localization

  • RNA stability assays comparing wild-type and ORF57-null conditions

How does ORF57 interact with host cell machinery?

KSHV ORF57 has been shown to interact with cellular RNA export factors, including the REF/Aly protein . This interaction is believed to facilitate the export of viral transcripts from the nucleus to the cytoplasm. Studies have identified specific regions of KSHV ORF57 involved in REF binding, multimerization, and RNA binding .

For OsHV-1 ORF57, researchers should investigate:

  • Potential interactions with invertebrate host export machinery using co-immunoprecipitation followed by mass spectrometry

  • The effects of ORF57 on host RNA processing pathways through transcriptome analysis

  • Functional conservation of interaction domains through mutational analysis

A proposed experimental approach for investigating OsHV-1 ORF57 interactions would include:

Experimental ApproachPurposeExpected Outcome
Yeast two-hybrid screeningIdentify host protein interactionsDiscovery of binding partners
Co-immunoprecipitationValidate direct interactionsConfirmation of complex formation
Domain mapping through mutationsIdentify functional regionsLocalization of interaction domains
Effects on host gene expressionAssess broader impactChanges in host transcriptome

What structural domains of OsHV-1 ORF57 are critical for its function?

While the specific domain structure of OsHV-1 ORF57 has not been fully characterized, insights can be drawn from studies of other herpesvirus ORF57 homologs. KSHV ORF57 functionality depends on specific regions involved in REF binding, multimerization, and RNA binding . Researchers investigating OsHV-1 ORF57 should consider:

  • Transmembrane domains: Hydrophobicity analysis of the OsHV-1 ORF57 sequence suggests the presence of transmembrane regions, which may be important for its subcellular localization and function.

  • RNA binding domains: Identification of potential RNA recognition motifs or other RNA-binding structures would be critical for understanding its interaction with viral transcripts.

  • Protein-protein interaction domains: Regions involved in interactions with cellular export machinery or other viral proteins would be essential for understanding its role in the viral life cycle.

A systematic approach to domain mapping would include:

Domain TypePrediction MethodsFunctional Validation
TransmembraneTMHMM, Phobius algorithmsSubcellular localization studies
RNA bindingBindN, RNABindR predictionsEMSA with domain mutants
Protein interactionConserved domain databaseY2H/Co-IP with truncation mutants

How can researchers distinguish between ORF57's direct effects on RNA stability versus export?

This is a sophisticated research question that requires careful experimental design. In KSHV, ORF57 has been shown to enhance both nuclear RNA stability and nuclear export of viral transcripts . To distinguish between these functions in OsHV-1 ORF57:

A comprehensive experimental approach would include:

AssayAnalysis MethodExpected Results
Pulse-chase with actinomycin DqRT-PCR at time intervalsDecay curves showing stabilization
Nuclear/cytoplasmic fractionationRNA-seq of compartmentsChanges in nuclear:cytoplasmic ratio
Reporter constructs with ORENorthern blottingEnhanced levels with ORF57
RNA FISHMicroscopy visualizationChanged RNA distribution patterns

Can ORF57 from different herpesvirus species complement each other functionally?

Studies with KSHV ORF57 and EBV SM (the Epstein-Barr virus homolog) have demonstrated that despite structural similarities, these proteins have virus-specific functions. EBV SM was unable to fully rescue lytic KSHV virion production in an ORF57-null mutant, although it did enhance some KSHV gene expression . Conversely, KSHV ORF57 could not rescue an SM-null EBV recombinant .

For researchers interested in OsHV-1 ORF57:

  • Cross-complementation experiments between OsHV-1 ORF57 and other herpesvirus homologs could reveal evolutionarily conserved versus divergent functions.

  • These experiments would be particularly interesting given the evolutionary distance between vertebrate and invertebrate herpesviruses.

  • Domain-swapping experiments could identify which regions confer virus-specific functions.

An experimental approach would include:

ExperimentMeasurementExpected Outcome
Complementation of KSHV ORF57-null with OsHV-1 ORF57Virion productionPartial or no rescue expected
Domain swappingFunctional rescueIdentification of critical regions
RNA target analysisRNA-seq or RIP-seqDifferent RNA binding profiles
Protein interaction studiesProteomic analysisDifferent host factor interactions

What are the optimal conditions for studying ORF57 RNA-protein interactions in vitro?

Based on studies with KSHV ORF57, several considerations are important when designing in vitro RNA-protein interaction experiments:

  • Protein preparation: Purified recombinant ORF57 should maintain native conformation. The E. coli-expressed His-tagged version provides a starting point , but researchers should confirm proper folding through circular dichroism or limited proteolysis.

  • RNA substrates: For initial studies, researchers might use known viral RNA sequences. In KSHV, ORF57 interacts with specific elements like the ORE in PAN RNA .

  • Buffer conditions: RNA-protein binding buffers typically contain:

    • 20mM HEPES pH 7.5

    • 100mM NaCl

    • 2mM MgCl₂

    • 1mM DTT

    • 0.1mg/ml BSA

    • 5% glycerol

    • RNase inhibitors

  • Detection methods: Fluorescence anisotropy, surface plasmon resonance, or EMSAs can quantitatively measure binding.

The following table outlines optimal experimental conditions for different assay types:

Assay TypeProtein Concentration RangeRNA ConcentrationIncubation Conditions
EMSA10-500nM1-10nM labeled RNA20min, 4°C
Fluorescence Anisotropy1-1000nM10nM fluorescent RNARoom temperature, equilibrium
Filter Binding1-500nM0.1-1nM labeled RNA30min, room temperature
SPR10-1000nMImmobilized RNAContinuous flow, 25°C

How can researchers establish appropriate animal or cell culture models for studying OsHV-1 ORF57 function?

Studying OsHV-1 ORF57 presents unique challenges compared to mammalian herpesviruses due to the invertebrate host system. Researchers should consider:

  • Primary oyster cell cultures: Though challenging to establish, primary cells from Pacific oysters (Crassostrea gigas) would provide the most relevant cellular context.

  • Heterologous expression systems: Human or other mammalian cell lines can be used to study specific aspects of ORF57 function, particularly for protein-protein interactions or effects on reporter constructs.

  • In vivo oyster models: Experimental infection of juvenile oysters can be used to study the effects of virus variants with mutations in ORF57.

  • Alternative approaches: Yeast models have been successfully used to study individual herpesvirus proteins and their interactions with cellular machinery.

A comprehensive research approach might include:

Model SystemApplicationsLimitations
Primary oyster cellsNative context for viral infectionDifficult to culture and manipulate
293T or HeLa cellsProtein localization, interaction studiesNon-native cellular environment
Saccharomyces cerevisiaeGenetic screening, protein interactionsLimited RNA processing pathways
Juvenile oystersIn vivo virus replication studiesComplex system, multiple variables

When designing these experiments, researchers should incorporate appropriate controls to account for the differences between cellular systems and establish clear metrics for functional assessment.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.